For many early-stage startups, choosing between a convertible note and a SAFE (Simple Agreement for Future Equity) is one of the first critical legal and strategic financing decisions. While both ...
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for ...
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $1 billion aggregate principal amount ...
CHICAGO--(BUSINESS WIRE)--Exelon Corporation (Nasdaq: EXC) announced the pricing of its offering of $900 million aggregate principal amount of its 3.25% convertible senior notes due 2029 in a private ...
Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million Viridian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results